NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 14 February 2013

Mixed manufacturing results at AMRI

AMRI reported development/small scale manufacturing revenues for 2012 were $35.7m, essentially flat with 2011. However, revenues for the large scale m rose 22% to $116.4m. Michael Nolan, AMRI's Vice President, Chief Financial Officer and Treasurer, said the company expects development and small scale revenues to rise up to 7% in 2013 and large scale revenue to rise up to 14%.
Seeking Alpha

No comments: